What is HC Wainwright’s Estimate for GALT FY2029 Earnings?
Galectin Therapeutics Inc. (NASDAQ:GALT – Free Report) – Analysts at HC Wainwright issued their FY2029 EPS estimates for Galectin Therapeutics in a report released on Wednesday, April 2nd. HC Wainwright analyst E. Arce expects that the company will post earnings of ($0.91) per share for the year. HC Wainwright has a “Neutral” rating on the […]
Galectin Therapeutics Inc. (NASDAQ:GALT – Free Report) – Analysts at HC Wainwright issued their FY2029 EPS estimates for Galectin Therapeutics in a report released on Wednesday, April 2nd. HC Wainwright analyst E. Arce expects that the company will post earnings of ($0.91) per share for the year. HC Wainwright has a “Neutral” rating on the […]
